Neisseria meningitidis

(redirected from Neisseria meningitis)

Neis·se·ri·a me·nin·gi·'ti·dis

a bacterial species found in the nasopharynx of humans but not in other animals; the causative agent of meningococcal meningitis and meningicoccemia; virulent organisms are strongly gram negative and occur singly or in pairs; in the latter case the cocci are elongated and are arranged with long axes parallel and facing sides kidney shaped; groups characterized by serologically specific capsular polysaccharides are designated by capital letters (the main serogroups being A, B, C, and D).

Neisseria meningitidis

Neisseria meningitidis

Meningococcus Infectious disease A gram-positive coccus which is part of the normal nasopharyngeal flora; it is one of the most common causes of meningitis in the US

Neis·se·ri·a me·nin·gi·ti·dis

(nī-sēr'ē-ă men-in-jit'i-dis)
A species found in the nasopharynx; the causative agent of meningococcal meningitis. Virulent organisms are strongly gram-negative and occur singly or in pairs; in the latter case the cocci are elongated and are arranged with long axes parallel and facing sides kidney shaped. Groups characterized by serologically specific capsular polysaccharides are designated by capital letters (the main serogroups being A, B, C, and D).
Synonym(s): meningococcus.

Neisser,

Albert Ludwig S., German physician, 1855-1916.
Neisseria catarrhalis
Neisseria flavescens
Neisseria gonorrhoeae - a species that causes gonorrhea in humans. Synonym(s): Neisser coccus
Neisseria lactamica
Neisseria meningitidis
Neisseria sicca
Neisseria subflava
Neisseria - a genus of aerobic to facultatively anaerobic bacteria (family Neisseriaceae) that are parasites of animals.
Neisseria mucosa
Neisser coccus - Synonym(s): Neisseria gonorrhoeae
Neisser diplococcus
Neisser syringe - a urethral syringe used in treatment of gonococcal urethritis.
References in periodicals archive ?
In parts of sub-Sahara Africa with the highest HIV prevalence, cryptococcal meningitis is now the leading cause of community-acquired meningitis ahead of Streptococcus pneumoniae and Neisseria meningitis (3).
The State Ministry of Health has so far collected 11 CSF [Cerebrospinal fluid] samples, these were tested and 8 of them tested positive for Neisseria Meningitis sero group A using latex agglutination testing (Pastorex rapid test)," partly reads the release, signed by Kariom Makur, the ministry's undersecretary.
Neisseria meningitis is a gram-negative bacterium that occasionally causes invasive disease in humans, primarily meningitis or sepsis (1).
Menactra was first licensed in January 2005, and it is indicated for use in persons aged 11 to 55 years to prevent invasive meningococcal disease caused by several Neisseria meningitis serogroups including A, C, and Y.
Menactra, which was first licensed in January 2005, is indicated for use in persons aged 11-55 years to prevent invasive meningococcal disease caused by several Neisseria meningitis serogroups including A, C, and Y.
Neisseria meningitis is one of the many bacteria that cause the disease.
The Group B version of the bacteria Neisseria meningitis claims about 150 lives a year.
SmithKline Beecham on July 30 announced that it has entered into an agreement with the Finlay Institute of Cuba regarding a vaccine to protect against a leading cause of Neisseria meningitis, a potentially crippling and fatal disease that typically strikes children, adolescents, and young adults:
Licensed in January 2005, Menactra is indicated for active immunization of individuals aged 11-55 years against invasive meningococcal disease cause by Neisseria meningitis serogroups A, C, Y, and W-135.
The genetic diversity of 134 serogroup X Neisseria meningitis isolates from Africa, Europe, and North America was analyzed by multilocus sequence typing and pulsed-field gel electrophoresis.
The results of the first study indicate that the Company's investigational trivalent meningococcal A/B/C conjugate vaccine may elicit immunologic memory to each of the three serogroups of Neisseria meningitis without interference.